Top compounds associated with response to CASP9


Feature Type Standardized
Nominal ANOVA
mRNA canertinib CTRPv2 pan-cancer AAC -0.11 0.003
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.003
mRNA CP466722 GDSC1000 pan-cancer AAC -0.089 0.003
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA nelarabine CTRPv2 pan-cancer AAC -0.11 0.004
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA alisertib CTRPv2 pan-cancer AAC -0.09 0.005
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.095 0.005
Download CSV